Replies to post #73 on Zimmer Biomet Holdings Inc (ZBH)

[DewDiligence]

ZBH reports 1Q23 results—raises 2023 guidance:

https://investor.zimmerbiomet.com/~/media/Files/Z/ZimmerBiomet-IR/press-release/zimmer-biomet-press-release-q1-2023.pdf

Guidance for 2023 non-GAAP EPS is now $7.40-7.50 (raised from $6.95-7.15). Guidance for 2023 revenue growth is now 5-6% (raised from 1.5-3.5%).

An increase in elective procedures is driving the updated guidance.